Skip to main content
. 2023 Feb 6;65:e13. doi: 10.1590/S1678-9946202365013

Table 3. Individual data for quantitative results of positive QFT-GIT and/or QFT-Plus from healthcare workers.

Subject NÂș TB, IU/ml (QFT-GIT) TB1, IU/ml (QFT-Plus) TB-TB1, IU/ml TB2, IU/ml (QFT-Plus) TB2-TB1, IU/ml
HCW1 0.82 0.76 0.06 0.52 -0.24
HCW2 0.18 0.16 0.02 0.57 0.41
HCW3 0.51 0.49 0.02 0.86 0.37
HCW4 4.82 2.53 2.29 2.04 -0.49
HCW5 5.21 1.72 3.49 1.73 0.01
HCW6 4.03 2.15 1.88 2.49 0.34
HCW7 1.90 1.38 0.52 2.14 0.76
HCW8 0.85 0.68 0.17 0.96 0.28
HCW9 0.05 0.39 -0.34 0.39 0
HCW10 2.41 1.47 0.94 -1.38 -2.85
HCW11 0.77 0.42 0.35 0.56 0.14
HCW12 3.52 2.17 1.35 1.29 -0.88
HCW13 0.28 0.23 0.05 0.66 0.43
HCW14 -0.05 0.26 -0.31 0.46 0.2
HCW15 1.96 0.65 1.31 0.57 -0.08
Average 1.82 1.03 0.79 0.92 -0.11

The bold digits represent the values used for reporting the testing result; the underlined elements represent the discordant results of QFT-GIT vs QFT-Plus.